483 Response Sparsha Pharma Usa Apr 2017

Cassandra Abellard FDA, Sonya Karsik FDA, Theresa Kirkham FDA, Walden Lee FDA, Marcus Yambot FDA$119.00 - Available Now

FDA investigators audited the Sparsha Pharma Usa - Oceanside, CA, United States facility and issued inspectional observation (via FDA 483) on 28 Apr 2017.

Product details

  • Category:
  • Inspection end: 28 Apr 2017
  • Location: Oceanside, United States
  • FEI: 3010888655
Add To Cart